Pharmaco - Press Releases

Date	Title	Company
14-Sep-2023	Biophytis Strengthens its Management Team with the Appointment of its Chief Business Officer	Biophytis
13-Sep-2023	Affluent Medical announces positive clinical results and further insights to enhance its strategy on Structural Heart activities	Affluent Medical SA
13-Sep-2023	Eckert & Ziegler collaborates with RefleXion Medical and Telix Pharmaceuticals to Expand Treatment Options for Prostate Cancer Patients	Eckert & Ziegler Strahlen- und Medizintechnik AG
13-Sep-2023	Sernova to Host Investor Calls to Introduce Newly Appointed CEO and Provide Business Update	Sernova Corp.
13-Sep-2023	Novo Nordisk conducts a two-for-one stock split	Novo Nordisk
13-Sep-2023	ABL Bio Taps into Synaffix ADC Technology to Accelerate Development of Bispecific ADC Products	Synaffix B.V.,
13-Sep-2023	Ad Scientiam Launches International Study to Assess Disability Progression in multiple sclerosis with MSCopilot®	Ad Scientiam
13-Sep-2023	Notice of Extraordinary General Meeting in Moberg Pharma AB (publ)	Moberg Pharma AB
13-Sep-2023	Interim results for the six months to 30 June 2023	Poolbeg Pharma plc
13-Sep-2023	Mainz Biomed’s ColoFuture Study, Evaluating its Novel mRNA Biomarkers, Reports Groundbreaking Topline Results Demonstrating Sensitivity for Colorectal Cancer of 94% with Specificity of 97% and Advance	Mainz BioMed N.V.
13-Sep-2023	Evolva and Nice & Green agree on improvements to financing agreement	Evolva Holding SA
12-Sep-2023	MorphoSys Receives U.S. FDA Fast Track Designation for Tulmimetostat in Endometrial Cancer	MorphoSys AG
12-Sep-2023	BRAIN Biotech AG: Scientist from BRAIN Biotech AG receives VAAM Innovation Award for the discovery of a novel CRISPR nuclease family	BRAIN Biotech AG
12-Sep-2023	CureVac Advances Seasonal Flu Study to Phase 2 in Collaboration with GSK Following Selection of Promising mRNA Vaccine Candidate with Broad Coverage	CureVac
12-Sep-2023	Six-Year Outcomes from Phase 3 CheckMate -227 Trial Show Durable, Long-Term Survival with Opdivo (nivolumab) Plus Yervoy (ipilimumab) in the First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer	Bristol Myers Squibb
12-Sep-2023	Cingulate Announces Pricing of $4.0 Million Public Offering	Cingulate
12-Sep-2023	Sosei Heptares’ partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of NBI-1117570 in Healthy Adults	Sosei Group Corporation
12-Sep-2023	CHEPLAPHARM opens swiss subsidiary and wins Agnes Wasem as Managing Director	Cheplapharm AG
12-Sep-2023	Biotest AG: Biotest treats first patient with severe community-acquired pneumonia in phase III trial with trimodulin	Biotest AG
12-Sep-2023	DEFENCE’S BROAD AND VERSATILE ACCUM® TECHNOLOGY PLATFORM FOCUS ON CANCER THERAPEUTICS	Defence Therapeutics Inc.